Evidence brief · Supplement

Idebenone for Mitochondrial disease (specific)

Evidence grade C — Niche, medical

Overall grade
Grade C
Last revised
1
graded outcome
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade C — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Mitochondrial disease (specific)Evidence grade C

    Niche, medical

    Moderatemixed

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Mitochondrial disease (specific) (grade C).

The evidence in words

The verdict

For mitochondrial disease (specific), Idebenone earns evidence grade C (moderate effect, mixed consistency) — the evidence is limited or mixed. Niche, medical

How it might work

It supports mitochondrial electron transport and has antioxidant activity, with better water solubility than CoQ10.

How to use it

Safety & cautions

Generally tolerated; medical uses are supervised.

Bottom line

A real drug for niche mitochondrial diseases, not a general nootropic. No case for healthy-person use.

Goes with

  • IdebenoneRead the full Idebenone monographEvidence grade C

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.